Arbutus Biopharma Corporation ABUS Current ratio

Current ratio at other companies

Arrowhead ResearchARWR

6.2×+1.1×

Gilead SciencesGILD

1.3×0.0×

ALN

Alnylam PharmaceuticalsALNY

3.1×+0.3×

AnaptysBio, Inc.ANAB

7.6×-0.7×

Avalo TherapeuticsAVTX

19.3×+6.9×

Assembly BiosciencesASMB

6.6×+4.6×

FAQ

What is Arbutus Biopharma Corporation's current ratio?

Arbutus Biopharma Corporation (ABUS) reported current ratio of 54.3× in Q1 2026.

How has Arbutus Biopharma Corporation's current ratio changed year-over-year?

Arbutus Biopharma Corporation's current ratio increased by 802.7% year-over-year, from 6× to 54.3×.

What is the long-term trend for Arbutus Biopharma Corporation's current ratio?

Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's current ratio has grown at a 3.3% compound annual growth rate (CAGR), from 13.4× to 15.7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.